Benzinga | Aug 4, 2021 08:11AM EDT

RBC Capital Maintains Outperform on Xylem, Raises Price Target to $140

RBC Capital analyst Deane Dray maintains Xylem (NYSE:XYL) with a Outperform and raises the price target from $127 to $140.